Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivo models to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by alpha smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concurrently, tissue inhibitors of metalloproteases (TIMPs) produced by HSCs are increased in experimental fibrosis, which could block the activity of their cognate enzymes and also prevent apoptosis of activated HSCs (278, 279).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Research works printed but not linked: 6
- Milani, 1992, Hepatology, 16, 186
- Vyas, 1995, 5, 399
- Saile, 1997, Am. J. Pathol., 151, 1265
- Li, 1999, Cancer Res., 59, 6267
- Ree, 1997, Clin. Cancer Res., 3, 1623
- Trim, 2000, Hepatology, 32, 183
Cited by
Items 401–431 of 431
Duffield, J. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00023-0
Towards treatment of viral pathogenesis
Griffiths, P. D. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.504
“Decreasing inflammation reduces TIMP, thus allowing activated stellate cells to be removed through apoptosis [24].”
BackgroundRelationships between TIMP-1, CAIX, and clinical outcomes in Egyptian breast cancer
Aly, R., Elghannam, D. M., & Yousef, A. B. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1712-x
“The association between high levels of TIMP-1 and a poor prognosis in breast cancer has been hypothesized to be the result of cancer-promoting functions recently demonstrated for TIMP-1, such as stimulation of proliferation and inhibition of apoptosis (Guedez et al. 1998; Murphy et al. 2002; Liu et al. 2003).”
BackgroundHepatic Stellate Cells in Hepatocellular Carcinogenesis: Possible Therapeutic Targets?
Vere, C. C. (2013) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.s12-006
“TIMP-1 also exerts an antiapoptotic effect on activated HSCs [83].”
BackgroundByström, P. (2010) · Figshare · Cited by 1
Matrix-leukocyte interactions in liver ischemia-reperfusion injury.
Duarte, S. M. C. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/67f5-1j52
Curcumin in hepatic stellate cell activation in health
Tang, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802972-5.00022-6
State-of-the-Art Lecture: Mechanisms of liver fibrosis — targets for therapy
Gordon‐Walker, T. T., Pellicoro, A., & Iredale, J. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-2759-7_15
Self-citationSato, M. (2009) · TSpace (University of Toronto)
Cangemi, V., & Fiori, E. (2009) · Springer eBooks · doi:10.1007/978-88-470-1085-7_10
Regulation of Metalloproteinase-dependent Ectodomain Shedding in Cytokine Biology and Inflammation
Murthy, A. (2012) · Library and Archives Canada (Government of Canada)
Antifibrotic Therapy for Liver Cirrhosis
Thủy, L. T. T., Hai, H., Hieu, V. N., Dat, N. Q., Hoang, D. V., & Kawada, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-7979-6_15
Vetter, D., & Friedman, S. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00007-8
Vetter, D., & Friedman, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1454-8.00006-0
(2004) · Journal of Biomedical Science · doi:10.1007/bf02254431
Current concept of hepatic fibrogenesis in mouse models of liver fibrosis
Scholten, D., & Brenner, D. A. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_12
Ahn, J., Park, J. H., Choi, H. J., Lee, D., Hong, H., Kim, O., & Kim, S. (2025) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2025.108.3.186 · Cited by 1
Vu, H., Sun, Y., Xiong, Z., Radford‐Smith, D. E., Causer, A., Nefzger, C. M., O'Sullivan, E. D., Watt, M. J., Ramm, G. A., Clouston, A. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644239
Eficàcia dels tocotrienols com a estratègia de tractament de la fibrosi intestinal
Cornadó, J. L. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
TIMP-1 as a Prognostic Marker in Colorectal Cancer
Frederiksen, C., Lomholt, A. F., Nielsen, H. J., & Brünner, N. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_33
The Effect of Somatostatin on Mediators of Liver Inflammation and Fibrosis in Viral Cirrhosis
Tsakou, A., Notas, G., Xidakis, C., Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2026) · Livers · doi:10.3390/livers6020016 · Cited by 1
“It was shown that TIMP-1 inhibits the apoptosis of activated HSCs, thus favoring the continuation of fibrosis [18].”
Etude de l'interaction du TIMP-1 avec ses récepteurs
Verzeaux, L. (2015) · theses.fr (ABES) · doi:10.70675/02b3787dze0bbz4a18z9bd2zc42bb1e85844
Monoacylglycerol Lipase, a new anti-inflammatory and anti-fibrogenic target in the liver
Chokr, D. (2018) · theses.fr (ABES) · doi:10.70675/6aac5cc4z3085z4939zb6c9ze439b795571f
Guilcher, C. L. (2018) · theses.fr (ABES) · doi:10.70675/31755573zc52bz4020zb736za39dcd3e9230
The paradox of TIMP-1: when inhibition fuels progression
Kemper, P. C. J., Huijbers, E. J. M., Koetsier, J., B, J. R. V. B., & Griffioen, A. W. (2026) · Trends Open · doi:10.1016/j.treopn.2026.04.007
Raj, A., & Kosey, S. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00644-8
“An imbalance between MMPs and their inhibitors (TIMPs), particularly TIMP-1, promotes the accumulation of ECM during this process [ 21 , 22].”
Mazhar, N., Khan, M. A., Majeed, A., & Akram, M. (2026) · Al-Najam Journal of Medical and Life Sciences · doi:10.68041/anjmls.v1i3/08
“In both human and animal models, TIMP-1 expression was consistently associated with the advancement of fibrosis, where it facilitated the formation of extracellular matrix and the recruitment of macrophages 34,35,36 .”
Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis
Harris, S., Tyagi, P., & Huebert, R. C. (2026) · Biomolecules · doi:10.3390/biom16101513
“First, TIMP-1 directly prolongs the lifespan of the cells driving the process: it inhibits apoptosis of activated HSCs through effects on MMP inhibition, classically via the CD63/ β 1-integrin complex, thereby preserving the fibrogenic cell population that sustains matrix deposition [40].”
InfluentialHashizume, N., Shin, R., Akiba, J., Matsui, T., Sotogaku, N., Koga, Y., Sotokawauchi, A., Masui, D., Sakamoto, S., Sugita, K., et al. (2026) · Pediatric Surgery International · doi:10.1007/s00383-026-06687-x
Rellevància del TNF i l’esfingomielinasa àcida en la fibrogènesi hepàtica
Tarrats, N. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H.
- Affiliations
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Murphy, Frank R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11069-11076
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164407945
- Cited by
- 432
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TIMP-1, hepatic stellate cells, apoptosis, matrix metalloproteinase inhibition, liver fibrosis, liver cirrhosis, alpha-smooth muscle actin, collagenase, serum deprivation, cycloheximide, nerve growth factor, TIMP-1 mRNA expression
- MeSH terms
- Animals, Cell Division, Cells, Cultured, Cycloheximide, Humans, Liver, Liver Cirrhosis, Apoptosis, Tissue Inhibitor of Metalloproteinase-1, Caspases, In Situ Nick-End Labeling, Rats, Caspase 3, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.